cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Neogenomics Inc
14 own
16 watching
Current Price
$0
$-0.23
(-1.34%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,208.2M
52-Week High
52-Week High
20.54
52-Week Low
52-Week Low
6
Average Volume
Average Volume
0.06M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
178.072
iconMarket Capitalization2,208.2M
icon52-Week High20.54
icon52-Week Low6
iconAverage Volume0.06M
iconDividend Yield--
iconP/E Ratio178.072
What does the Neogenomics Inc do?
NeoGenomics, Inc., together with its subsidiaries, operates a network of cancer-focused genetic testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry and digital imaging testing services to localize proteins in cells of a tissue section, as well as to allow clients to see and utilize scanned slides, and perform quantitative analysis for various stains; and molecular testing services that focus on the analysis of DNA and RNA, and the structure and function of genes at the molecular level. The company also provides pathology consultation services for clients in which its pathologists review surgical samples on a consultative basis; and testing services in support of its pharmaceutical clients' oncology programs, as well as acts as a reference laboratory supplying anatomic pathology testing services. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
Read More
How much money does Neogenomics Inc make?
News & Events about Neogenomics Inc.
Zolmax
2 months ago
Needham & Company LLC restated their buy rating on shares of NeoGenomics (NASDAQ:NEO Get Rating) in a research report report published on Wednesday morning, Benzinga reports. They currently have a $21.00 target price on the medical research companys stock. Other research analysts have also recently ...
Business Wire
2 months ago
Massive Bio, Inc., a private AI-enabled oncology startup that provides virtual and in-person concierge services for cancer patients, and NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced a...
Accesswire
2 months ago
FT MYERS, FL / ACCESSWIRE / March 16, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, announced today the commercial availability of the RaDaR® assay, a liquid biopsy test for molecular/minimal residual disease (MRD). MRD...
Ticker Report
3 months ago
NeoGenomics (NASDAQ:NEO Get Rating) and BioNano Genomics, Inc. WT EXP 082123 (NASDAQ:BNGOW Get Rating) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ...
Ticker Report
3 months ago
NeoGenomics (NASDAQ:NEO Get Rating) and BioNano Genomics, Inc. WT EXP 082123 (NASDAQ:BNGOW Get Rating) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, ...
Frequently Asked Questions
Frequently Asked Questions
What is Neogenomics Inc share price today?
plus_minus_icon
Can Indians buy Neogenomics Inc shares?
plus_minus_icon
How can I buy Neogenomics Inc shares from India?
plus_minus_icon
Can Fractional shares of Neogenomics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Neogenomics Inc stocks?
plus_minus_icon
What is today’s traded volume of Neogenomics Inc?
plus_minus_icon
What is today’s market capitalisation of Neogenomics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Neogenomics Inc?
plus_minus_icon
What percentage is Neogenomics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Neogenomics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.23
(-1.34%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
National HealthCare Corporation
National HealthCare Corporation
$62.45
$0.00 (0.00 %)
Veracyte, Inc.
Veracyte, Inc.
$25.67
$-0.23 (-0.89 %)
Addus HomeCare Corp
Addus HomeCare Corp
$94.02
$-0.30 (-0.32 %)
Gen Digital Inc.
Gen Digital Inc.
$17.96
$0.18 (1.00 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
National HealthCare Corporation
National HealthCare Corporation
$62.45
$0.00 (0.00 %)
Veracyte, Inc.
Veracyte, Inc.
$25.67
$-0.23 (-0.89 %)
Addus HomeCare Corp
Addus HomeCare Corp
$94.02
$-0.30 (-0.32 %)
Gen Digital Inc.
Gen Digital Inc.
$17.96
$0.18 (1.00 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00